🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
PRA Health Sciences
Start Date
2015-09-15
Trial ID
NCT02742779
This is a first-in-human study aimed at determining the safety of a single ...
Status
Recruiting
Location
Charité Research Organization gmbh
Start Date
2025-10-06
Trial ID
NCT07181369
Treatments Being Tested
This study is to characterize the pharmacodynamic characteristics and to as...
Status
Completed
Location
Investigational Site 203
Start Date
2022-03-24
Trial ID
NCT05161156
Primary objective: To assess the safety and tolerability of single ascendi...
Status
Completed
Location
Investigator Site
Start Date
2017-06-05
Trial ID
NCT03172208
A study to assess safety, tolerability and clinical effects of single and r...
Status
Completed
Location
Premier Medical Associates
Start Date
2020-01-23
Trial ID
NCT04229225
The objective of this study is to investigate the pharmacokinetics, safety,...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01935479
The objectives of the proposed study are to determine 1) the effect of a si...
Status
Completed
Location
University of Miami Divison of Pulmonary and Critical Care Medicine
Start Date
2013-02
Trial ID
NCT02097992
Treatments Being Tested
The main purpose of this study is to test an investigational drug known as ...
Status
Active Not Recruiting
Location
Invivyd Investigative Site
Start Date
2026-01-08
Trial ID
NCT07298434
Treatments Being Tested